Risk in the context of genetics refers to the probability that one individual will be affected by a particular genetic disorder. Both genes and environment influence risk and an individual’s risk may be higher because of the inhibitions that cause or increase susceptibility to a disorder. We have advances in technology that now enable us to obtain the sequence of and individuals of many tens of thousands of genes so, this makes it possible to measure polygenic score, for example, but it is still unclear whether there is sufficient difference on a gene by gene basis to accurately determine risk on the individual level. So, finally an alternative approach is to group genes based on the molecular physiological products, they control diagnostic tests that could then be designed to measure irregularities in these intermediate phenotypes so for patients these genetic informations could be used to select the best pathetic strategies.
In genetics, some single-gene mutations do not show 100% penetrance. The classic example of this is the Bracken gene mutations in humans. It usually affects women, but it also affects men. If they’ve got a bad mutation, you have a 90% chance of developing breast cancer. For most people, this risk is too high, and they are offered a double mastectomy. Quite a few fertility gene mutations may not be 100% penetrant; for example, a new mutation was found in inversion in males of Eastern Polish, Czech, and Slovakian. They’ve got an inversion of 1.6 million records on the Y chromosome. Most of these males have normal fertility. However, if they’ve got this inversion and they’re an older father, they are eight times more likely to have other DNA letter changes in that region, and that causes infertility. Geneticists, therefore, offer percentage risk scores; the patient can then decide their own course of action based on the risk score.
